Regulatory Pathway Case Studies to Gain Phase 2 Approval Using Known Products for New Indications
Time: 2:10 pm
day: Day One Clinical Track PM
Details:
- Repurposing products for new indications with minimal capital investment
- Detailing the process of taking existing pools of data combined with phase 1 safety data to create a regulatory filing
- Discussing the benefits of this approach in minimizing costs and minimising risk
